If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 1993 Ph.D. (Pathology), Institute of Pathology, National Taiwan University
  • 1985 M.S. (Pathology), Institute of Pathology, National Taiwan University
  • 1982 Bachelor (Medicine), China Medical College

Awards

  • 2013 The Best Teaching Attending Physician Award, Taipei Medical University-Shuang Ho Hospital
  • 2010.08The Faculty Award, Taipei Medical University
  • 2009 The Faulty Teaching Award, Taipei Medical University (WanFang Hospital)
  • 2009 The Faulty Teaching Award, Taipei Medical University
  • 2006.02The Faulty Teaching Award, Taipei Medical University (WanFang Hospital)
  • 2005 The Faulty Teaching Award, Taipei Medical University (WanFang Hospital)
  • 2005 Outstanding Award of Contest of Published Paper and Posters, Taipei WanFang Hospital
  • 1994 Professor Shu Yeh’s Award in Pathology (Ph.D. Section)
  • 1987 Professor Shu Yeh’s Award in Pathology for Outstanding Pathology Research
  • 1986 Qualified Pathologist in Taiwan (No. 063)
  • 1986 Professor Shu Yeh’s Award in Pathology (Graduate Student Section)

Experience

  • 2014.02-Director, Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
  • 2013.09-Associate Dean, College of Medicine, Taipei Medical University, Taipei, Taiwan
  • 2007.03-2010.07 Director, Medical Education and Research, Taipei Municipal WanFang Hospital, Taipei Medical University, Taipei, Taiwan
  • 2007.04-2009.12 Committee member, OSCE committee, Taiwan Society of Medical Education
  • 2006.07-2010.07 Director, Center for Faculty Development, Taipei Municipal WanFang Hospital, Taipei Medical University, Taipei, Taiwan
  • 2005.04-2010.07 Director, Clinical Skill Center and OSCE Center, Taipei Municipal WanFang Hospital, Taipei Medical University, Taipei, Taiwan
  • 2003.09-2014.10 Director, Department of Pathology, Taipei Municipal WanFang Hospital, Taipei Medical University, Taipei, Taiwan
  • 2003.09 Professor, Department of Pathology, School of Medicine, Taipei Medical University, Taipei, Taiwan
  • 2002-2003 Chief and Professor, Department of Pathology, China Medical College, Taichung, Taiwan
  • 2002-2003 Chief and Professor, Department of Pathology, China Medical College Hospital, Taichung, Taiwan
  • 1999-2001 Chief and Associate Professor, Department of Pathology, China Medical College Hospital, Taichung, Taiwan
  • 1996-1997 Research Fellow of Cardiovascular Pathology and Transplantation Immunology, Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland, U.S.A.
  • 1994-1999 Associate Professor and Staff Pathologist, Department of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan
  • 1990-1992 Research Fellow, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, U.S.A.
  • 1986-1994Instructor and Staff Pathologist, Department of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan

Research Interests

  • Pathology
  • Oncologic Pathology
  • Novel biomarkers in cancers

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 60 Similar Profiles
Human Herpesvirus 4 Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Biopsy Medicine & Life Sciences
Marginal Zone B-Cell Lymphoma Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Membrane Proteins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2019

RAB3C在大腸直腸癌轉移之分子機制探討(2/3)

Chen, C.

8/1/187/31/19

Project: b - Ministry of Science and Technology

RAB3C在大腸直腸癌轉移之分子機制探討(1/3)

Chen, C.

8/1/177/31/18

Project: b - Ministry of Science and Technology

Research Output 1986 2018

  • 2953 Citations
  • 31 h-Index
  • 160 Article
  • 2 Comment/debate
Glioblastoma
Cell Cycle
Growth
Minimally Invasive Surgical Procedures
Robotics
Rectal Neoplasms
Surgery
Neoadjuvant Therapy
8 Citations

Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via β-hydroxybutyrate

Huang, C. K., Chang, P. H., Kuo, W. H., Chen, C. L., Jeng, Y. M., Chang, K. J., Shew, J. Y., Hu, C. M. & Lee, W. H., Mar 10 2017, In : Nature Communications. 8, 14706

Research output: Contribution to journalArticle

transporter
3-Hydroxybutyric Acid
Adipocytes
breast
Tumors

BICD1 expression, as a potential biomarker for prognosis and predicting response to therapy in patients with glioblastomas

Huang, S. P., Chang, Y. C., Low, Q. H., Wu, A. T. H., Chen, C. L., Lin, Y. F. & Hsiao, M., Jan 1 2017, In : Oncotarget. 8, 69, p. 113766-113791 26 p.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Biomarkers
Atlases
Glioma

Correction: Inflammation promotes expression of stemness-related properties in hbv-related hepatocellular carcinoma (PLoS ONE (2016)11:2 (e0149897) DOI: 10.1371/journal.pone.0149897)

Chang, T. S., Chen, C. L., Wu, Y. C., Liu, J. J., Kuo, Y. C., Lee, K. F., Lin, S. Y., Lin, S. E., Tung, S. Y., Kuo, L. M., Tsai, Y. H. & Huang, Y. H., Jan 1 2017, In : PLoS One. 12, 1, e0171176

Research output: Contribution to journalComment/debate

Organized Financing
hepatoma
funding
Hepatocellular Carcinoma
inflammation